Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Prostate Cancer
Interventions
OTHER

STAND-T platform

Internet-based intervention comprised of evidence-based, patient materials and resources

OTHER

Survey Administration

Satisfaction and follow-up surveys will be administered to participants

OTHER

Text Messages

Participants will receive periodic text messages

Trial Locations (2)

94110

Zuckerberg San Francisco General Hospital, San Francisco

94142

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Myovant Sciences GmbH

INDUSTRY

lead

University of California, San Francisco

OTHER